Cite

HARVARD Citation

    Halpin, D. et al. (n.d.). P148 Once-daily tiotropium Respimat® add-on to at least ICS maintenance therapy reduces exacerbation risk in patients with uncontrolled symptomatic asthma. Thorax. p. A151. [Online]. 
  
Back to record